Buying and Selling Specials in 2012 What the NHS customer

Download Report

Transcript Buying and Selling Specials in 2012 What the NHS customer

Buying and Selling Specials in 2012
What the NHS customer wants
How the contracting process helps them to get it
Jane Page
Principal Pharmacist Medicines Procurement
University Hospitals of Leicester
NHS Customer…
The view from here.......
• UHL - large NHS Trust (not yet an FT)
- no pharmacy production unit
• East Midlands
- other large Trusts with production units
- no “Regional” production unit
- modernisation money went into QA
Unlicensed Medicines
• Seemingly undiminished need
• Over 10% of drug catalogue unlicensed
• A big headache for procurement staff
What does the NHS Customer want?
• The NHS customer – THE PATIENT wants
•
•
•
•
Safe medicine
Effective medicine
Available when needed
Low cost (it’s taxpayers’ money)
How do we ensure SAFETY ?
•
•
•
•
Chief Pharmacist responsibility
Trust Unlicensed Medicines Policy
Risk Assessment
Clinical risk – evidence for use, risk of harm, side
effects, therapeutic window
• Pharmaceutical risk – source of supply, production
process, product specification and QA
• Bond and release process on receipt
How does the procurement process ensure
delivery of safe medicines on time?
• Choice of supplier – appropriately licensed, QA
audited, performance record
• Product specifications
• Certificates of Analysis
.....but are we getting the best price?
How easy is all this?
• ProFile is really useful
• Manufacturers’ information more readily
available
BUT
• More and more companies knocking on the door
• Competitive pricing
• Need for quality assurance
Contracting
•
•
•
•
•
•
Stops the doorbell ringing
Stable source of supply
Improves quality assurance
Ensures value for money
Meets EU and public sector procurement rules
Any qualified provider
Contracting Process
• Service to supply unlicensed medicines
• Includes examples of products required and
potential volumes
• EM contracts for unlicensed medicines are
framework contracts with a number of suppliers
awarded to the framework . Each supplier is
awarded specified products and volumes, with any
new products required subject to mini-competition
Contracting Process
• Advertisement – we find out how many potential suppliers
there are
• PQQ – checks suppliers are qualified to tender
• ITT – detailed specification of service required. Allows
suppliers to tell us in detail what they can deliver
• Evaluation of supplier offers
• Adjudication – side by side comparison of offers
• Award
• Implementation
• Contract Management and KPIs
What are we looking for?
• Quality Management System
• Evidence of control of raw materials, production
process, QC, finished products, staff training,
documentation
• Products which meet specification
• Labelling in accordance with NPSA guidance
• Flexibility to change labels to meet our needs
• Certificates of Analysis
Evaluation
• ITT – answer questions fully and include relevant
documentation as evidence
• Products – samples should be correctly labelled
and packaged as for hospital delivery
• Documentation – product specification, stability
data, Cof A
• Presentation – make it relevant
• Contingency plans
• Price – evaluated last
Categories
•
•
•
•
•
Dose banded chemotherapy
“ready to use” injectables
Infusions for home delivery
Imported medicines (unlicensed)
Specials (UK compounded unlicensed
medicines)
Thank you.....
......and any questions?